Xueda Education Q3 Results, Dynasil Subsidiary Gets Grants by

New Post Public Reply Private Reply Replies (0) Message Board
karnacua2

http://pennyomega.com/img/xue.jpg Xueda Education Group (XUE)

XUE reported on its financial results, not only robust operating results for the third quarter but for the first time in XUE ’s history, positive net earnings results in the third quarter period..

For the third quarter 2013, XUE posted total net revenues of $79.4 million, a 14.2% increase year over year, gross profit of $23.2 million, increased by 74.3% compared to the same period the prior year, and net income attributable to XUE of $1.2 million, compared to a net loss of $3.6 million in the third quarter of 2012.

Diluted net income attributable to XUE per American Depositary Share (ADS) for the third quarter of 2013 was $0.02, compared to a diluted net loss per ADS of ($0.05) for the third quarter of 2012.

http://pennyomega.com/img/xue_chart.png

XUE is a leading national provider of personalized tutoring services for primary and secondary school students in China.

More about Xueda Education Group (XUE) at ir.xueda.com .

**

http://pennyomega.com/img/crwe_logo.jpg Crown Equity Holdings Inc. (CRWE)

Corporate buyers are comfortable and willing to make major purchase online, and many are already doing this, but not on suppliers’ web sites. With online spend expected to rise in the next year, suppliers who don’t invest in e-commerce and multichannel initiatives will miss out on revenue gains from this channel

U.S. companies and government agencies will purchase $559 billion via the web in 2013, Forrester Research Inc. predicted in its first estimate of the b2b e-commerce market released last year.

CRWE is looking to deliver value for its stockholders in both the near and long term, and to improve the potential future growth for the company, CRWE is targeting the multi-billion dollar online b2b market with its iB2B Global project..

http://pennyomega.com/img/crwenov19.png

As a worldwide online multi-media publisher, CRWE ‘s advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. The company launches, invests and manages select businesses, projects and real estate endeavors.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com .

**

http://pennyomega.com/img/dysl1.jpg Dynasil Corporation of America (DYSL)

DYSL reported that its contract research subsidiary, RMD Inc., has received four grants totaling $4.0 million under the U.S. Department of Energy's Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs.

From accounting for the country's nuclear fuel supply to monitoring the 15 million shipping containers that enter the U.S.' ports every year for illicit nuclear materials, the new Phase II research projects DYSL 's RMD is undertaking through these SBIR/STTR Programs exemplify some of the world's most demanding security and safety needs.

DYSL 's RMD work has significant application in the prevention of terrorist attacks and the safe guarding of nuclear materials, as well as in commercial endeavors such as energy exploration, nuclear power plant safety, medical imaging, basic science research and non-destructive testing.

http://pennyomega.com/img/dysl_chart.png

DYSL develops and manufactures detection and analysis technology, precision instruments and optical components for the homeland security, medical and industrial markets including medical imaging and sensors for non-destructive testing.

More about Dynasil Corporation of America (DYSL) at www.dynasil.com .

**

http://pennyomega.com/img/imgn.jpg ImmunoGen, Inc. (IMGN)

IMGN reported that the European Commission has granted marketing approval for Kadcyla (trastuzumab emtansine; ado-trastuzumab emtansine in the US) in the European Union (EU). This event triggers a $5 million milestone payment to IMGN.

Kadcyla has been approved for the treatment of adult patients with HER2-positive, unresectable locally advanced or metastatic breast-cancer who previously received Herceptin(R) (trastuzumab) and a taxane, separately or in combination.

As with the Kadcyla approvals that have been granted in the US, Japan, and other geographies, the approval in the EU is based on the findings in the EMILIA Phase III trial. In the EU and other international markets, the timing of the commercial availability of Kadcyla after approval can vary due to national differences in processes for establishing pricing/reimbursement, with some countries – including Germany – able to launch shortly after approval.

Kadcyla consists of Roche’s trastuzumab antibody with IMGN ’s DM1 cytotoxic agent attached using one of the Company’s engineered linkers. Roche has global development and commercialization rights for Kadcyla; IMGN is entitled to receive royalties on product sales as well as specified milestone payments.

http://pennyomega.com/img/imgn_chart.png

IMGN develops targeted anticancer therapeutics. Its ADC technology uses a tumor-targeting engineered antibody to deliver one of IMGN 's highly potent cancer-cell killing agents specifically to tumor cells.

More about ImmunoGen, Inc. (IMGN) at www.immunogen.com .

**

Read Full Disclaimer at www.drstockpick.com/disclaimer

Xueda Education Group (XUE) Stock Research Links

XUE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 348

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading

Top 5 Most Recently Viewed Articles

GE HealthCare Launches Innovative Ultrasound Systems for Women

Updated Category News Views 289

GE HealthCare Unveils New Voluson Expert Series Ultrasound Systems GE HealthCare recently announced the launch of its enhanced Voluson Expert Series ultrasound systems, aiming to improve early detection and streamline exam efficiency in women's healthcare. With FDA 510(k) clearance achieved, these innovative systems—Voluson Expert 22, 20, and 18—combine...

Continue Reading
Newmont Corp: Dominating Gold Mining with Impressive Gains

Updated Category News Views 291

Newmont Corp's Standout Performance In a market filled with technology giants, Newmont Corp (NYSE: NEM) is making headlines for its remarkable performance this year. Rising an astonishing 106% year-to-date (YTD), the largest gold miner is turning ore into a sought-after treasure for investors. The stability of gold prices amid ongoing inflation concerns has positioned...

Continue Reading
Seeking Justice: Class Action Lawsuit for Fiserv, Inc. Investors

Updated Category News Views 221

Overview of the Fiserv, Inc. Class Action Investors who have experienced significant losses in Fiserv, Inc. (NYSE: FI) stock are encouraged to take action. Robbins LLP is currently leading a class action lawsuit, aimed at helping those impacted during a specific class period of the company’s troubling financial disclosures. Why Join the Class Action? This initiative is...

Continue Reading
Lepage Millwork to Acquire Custom Window Maker Fenêtres MQ

Updated Category News Views 262

Big Move in Windows: Lepage Eyes Fenêtres MQ Dust off those old window ledgers, folks, because we've got a shake-up in the custom luxury window game. Lepage Millwork, a family-run titan in the North American fenestration scene, is gearing up to take over Fenêtres MQ from the big shots over at Andersen. We're talking about an ownership shift set to seal the deal by...

Continue Reading
Probe Gold's Annual Meeting Highlights Key Voting Outcomes

Updated Category News Views 181

Key Highlights from Probe Gold's Annual General Meeting Probe Gold Inc., with its stock traded as TSX: PRB and OTCQB: PROBF, held its Annual General Meeting (AGM) where significant decisions were made that will shape the company's future. This meeting was filled with exciting developments as shareholders came together to participate in the governance of the company....

Continue Reading